The consensus among Wall Street analysts is that investors should "hold" Translate Bio stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TBIO, but not buy additional shares or sell existing shares. View analyst ratings for Translate Bio or view top-rated stocks.Why did TBIO stock explode 73% higher on August 2?
TBIO stock exploded 73% higher in after-hours trading on August 2, 2021, after the news came out that Sanofi made a bid to buy the company.What is transtranslate bio's (TBIO) Q4 earnings results?
Translate Bio, Inc. (NASDAQ:TBIO) announced its quarterly earnings results on Wednesday, August, 4th. The company reported $0.21 EPS for the quarter, topping the Zacks' consensus estimate of ($0.23) by $0.44. The firm earned $72.65 million during the quarter, compared to analysts' expectations of $38.23 million.What are analysts' price targets for Translate Bio's stock?
9 brokerages have issued 1 year price targets for Translate Bio's stock. Their forecasts range from $19.00 to $38.00. On average, they expect Translate Bio's stock price to reach $26.29 in the next twelve months. This suggests that the stock has a possible downside of 29.6%.